title: [Application of rivaroxabane in patients with proteins C and S deficiency].
authors.forename: A A
authors.initials: AA
authors.lastname: Poliantsev
authors.forename: D V
authors.initials: DV
authors.lastname: Frolov
authors.forename: D V
authors.initials: DV
authors.lastname: Linchenko
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Shchelokova
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D001777:Blood Coagulation / Q000187:drug effects*; D004145:Diosmin / Q000008:administration & dosage*; D004338:Drug Combinations; D016903:Drug Monitoring; D005260:Female; D006569:Hesperidin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage*; D020151:Protein C Deficiency / Q000097:blood / Q000150:complications; D018455:Protein S Deficiency / Q000097:blood / Q000150:complications; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D013995:Time; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
chemical_list: D000925:Anticoagulants; D004338:Drug Combinations; D009025:Morpholines; D013876:Thiophenes; C080675:S 5682; D004145:Diosmin; D000069552:Rivaroxaban; D006569:Hesperidin